Related articles:

NanoString Technologies Inc.: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook
March 01, 2017
March 1, 2017

NanoString Technologies Inc.: NanoString Technologies to Release Fourth Quarter and Fiscal Year 2016 Financial Results and Host Conference Call on Wednesday, March 1, 2017
February 24, 2017
February 24, 2017

NanoString Technologies Inc.: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016
January 10, 2017
January 10, 2017

NanoString Technologies Inc.: NanoString Technologies to Release Third Quarter 2016 Financial Results and Host Conference Call on Wednesday, November 2, 2016
October 05, 2016
October 5, 2016

NanoString Technologies Inc.: NanoString Technologies Releases Operating Results for Second Quarter of 2016
August 03, 2016
August 3, 2016

NanoString Technologies Inc.: NanoString Technologies to Release Second Quarter 2016 Financial Results and Host Conference Call on Wednesday, August 3, 2016
July 07, 2016
July 7, 2016

NanoString Technologies Inc.: NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
June 02, 2016
June 2, 2016

NanoString Technologies Inc.: NanoString Technologies Releases Operating Results for First Quarter of 2016
May 05, 2016
May 5, 2016

NanoString Technologies Inc.: NanoString Technologies to Release First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5, 2016
April 13, 2016
April 13, 2016

NanoString Technologies Inc.: NanoString Technologies and HalioDx Enter Into Collaboration Agreement to Jointly Develop and Commercialize Novel Gene Expression Assays in Immuno-oncology
April 11, 2016
April 11, 2016

NanoString Technologies Inc.: NanoString Technologies and Cell Signaling Technology Announce Agreement to Expand Suite of 3D Biology Assays
March 10, 2016
March 10, 2016

NanoString Technologies Inc.: NanoString Technologies and Merck Expand Collaboration to Develop and Commercialize Novel Diagnostic Test to Predict Response to KEYTRUDA® (pembrolizumab)
February 29, 2016
February 29, 2016

NanoString Technologies Inc.: NanoString Technologies Releases Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Outlook
February 29, 2016

NanoString Technologies Inc.: NanoString Technologies to Release Fourth Quarter 2015 Financial Results and Host Conference Call on Monday, February 29, 2016
February 12, 2016
February 12, 2016

NanoString Technologies Inc.: NanoString Technologies Provides Preliminary Operational and Financial Results for 2015
January 10, 2016
January 10, 2016

NanoString Technologies Inc.: NanoString Technologies Enters Into Collaboration Agreement With Medivation and Astellas to Develop Novel Companion Diagnostic Test
January 07, 2016
January 7, 2016

NanoString Technologies Inc.: NanoString Technologies Releases Financial Results for Third Quarter of 2015
November 02, 2015
November 2, 2015

NanoString Technologies Inc.: NanoString Technologies Releases Financial Results for Second Quarter of 2015
August 04, 2015
August 4, 2015

NanoString Technologies Inc.: NanoString Technologies to Release Second Quarter 2015 Financial Results and Host Conference Call on Tuesday, August 4, 2015
July 21, 2015
July 21, 2015

NanoString Technologies Inc.: Merck and NanoString Announce Clinical Research Collaboration to Develop an Immune-Related Gene Expression Assay for Use in the Development Program for KEYTRUDA® (pembrolizumab)
May 28, 2015
May 28, 2015

NanoString Technologies Inc.: NanoString Technologies Releases Financial Results for First Quarter of 2015
May 06, 2015
May 6, 2015

NanoString Technologies Inc.: NanoString Technologies and Cancer Immunotherapy Trials Network (CITN) Enter Into a Collaboration to Identify Biomarker Assays for Novel Cancer Immunotherapies
May 05, 2015
May 5, 2015

NanoString Technologies Inc.: NanoString Technologies to Release First Quarter 2015 Financial Results and Host Conference Call on Wednesday, May 6, 2015
April 22, 2015
April 22, 2015

NanoString Technologies Inc.: NanoString Technologies and MD Anderson to Collaborate on Development of Multi-Omic Assays Simultaneously Profiling Gene and Protein Expression
April 01, 2015
April 1, 2015

NanoString Technologies Inc.: NanoString Technologies Appoints Robert Hershberg, M.D., Ph.D. to Its Board of Directors
March 03, 2015
March 3, 2015

NanoString Technologies Inc.: NanoString Technologies Releases Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Outlook
February 24, 2015
February 24, 2015

NanoString Technologies Inc.: NanoString Technologies to Release Fourth Quarter 2014 Financial Results and Host Conference Call on Tuesday, February 24, 2015
February 10, 2015
February 10, 2015

NanoString Technologies Inc.: NanoString Technologies Provides Update on 2014 Operational and Preliminary Financial Results
January 08, 2015
January 8, 2015

NanoString Technologies Inc.: NanoString Technologies Releases Financial Results for Third Quarter of 2014
November 04, 2014
November 4, 2014

NanoString Technologies Inc.: NanoString Technologies to Release Third Quarter 2014 Financial Results and Host Conference Call on Tuesday, November 4, 2014
October 09, 2014
October 9, 2014

NanoString Technologies Inc.: NanoString Technologies Appoints Veteran Diagnostics Executive Tina S. Nova, Ph.D. to Its Board of Directors
April 30, 2014
April 30, 2014

NanoString Technologies Inc.: NanoString Technologies Prices Follow-On Offering
January 23, 2014
January 23, 2014

NanoString Technologies Inc.: NanoString Technologies Launches Follow-On Offering
January 21, 2014
January 21, 2014

NanoString Technologies Inc.: NanoString Technologies Files Registration Statement With SEC for a Follow-On Public Offering
January 13, 2014
January 13, 2014

NanoString Technologies Inc.: NanoString Technologies Announces Preliminary Unaudited Fourth Quarter 2013 Revenue
January 13, 2014

Pin It on Pinterest

Share This